Bruno Eymard Selected Research

Bruno Eymard Research Topics

Disease

31	Muscular Diseases (Myopathy) 01/2021 - 10/2003
15	Myasthenia Gravis 01/2021 - 10/2004
13	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 12/2020 - 03/2003
9	Congenital Structural Myopathies (Centronuclear Myopathy) 01/2021 - 11/2005
8	Muscle Weakness 04/2019 - 07/2007
8	Myotonic Dystrophy (Dystrophia Myotonica) 12/2018 - 10/2003
7	Muscular Dystrophies (Muscular Dystrophy) 01/2019 - 08/2007
6	Distal Myopathies (Distal Muscular Dystrophy) 01/2017 - 12/2008
5	Nemaline Myopathies (Nemaline Myopathy) 01/2022 - 12/2013
5	Dysferlinopathy 01/2021 - 08/2005
4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 11/2004
4	Atrophy 01/2020 - 09/2004
4	Myofibrillar Myopathy 06/2018 - 07/2005
4	Myositis (Idiopathic Inflammatory Myopathies) 01/2016 - 06/2011
4	Autoimmune Diseases (Autoimmune Disease) 02/2014 - 10/2004
3	Thymoma (Thymic Carcinoma) 01/2020 - 02/2006
3	Disease Progression 01/2018 - 06/2007
3	Glycogen Storage Disease Type II (Pompe's Disease) 01/2017 - 09/2003
3	Inclusion Body Myositis 01/2013 - 10/2003
3	type 2B Limb-girdle muscular dystrophy 02/2009 - 08/2005
2	Central Core Myopathy (Central Core Disease) 01/2021 - 11/2017
2	Bethlem myopathy 01/2021 - 10/2010
2	Scleroatonic muscular dystrophy 01/2021 - 10/2010
2	Malignant Hyperthermia 01/2021 - 11/2017
2	Muscle Hypotonia (Hypotonia) 01/2021 - 03/2009
2	Neuromuscular Diseases (Neuromuscular Disease) 08/2019 - 03/2013
2	Fibrosis (Cirrhosis) 08/2019 - 04/2015
2	Hearing Loss (Hearing Impairment) 01/2018 - 05/2014
2	Glycogen Storage Disease Type III (Cori's Disease) 11/2017 - 05/2015
2	Glycogen Storage Disease (Glycogenosis) 10/2017 - 08/2010
2	Neoplasms (Cancer) 09/2017 - 01/2016
2	Neuromuscular Junction Diseases 09/2017 - 09/2014
2	Foot Deformities (Foot Deformity) 01/2017 - 05/2014
2	Sudden Death 01/2017 - 11/2015
2	Dermatomyositis (Dermatopolymyositis) 01/2016 - 01/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2015 - 06/2015
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2015 - 12/2013
2	Sarcoglycanopathies 04/2015 - 02/2012
2	Cap Myopathy 07/2014 - 12/2013
2	Arthrogryposis 07/2014 - 05/2014
2	Respiratory Insufficiency (Respiratory Failure) 05/2014 - 07/2011
2	Oculopharyngeal Muscular Dystrophy 01/2014 - 08/2006
2	Thymus Hyperplasia 03/2013 - 10/2004
2	Myotonic Disorders (Paramyotonia Congenita) 04/2010 - 09/2004
2	Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic) 04/2010 - 03/2009
2	Paralysis (Palsy) 03/2009 - 11/2004
2	Miyoshi myopathy 02/2009 - 08/2005
2	Protein Deficiency 02/2009 - 08/2007
2	Ophthalmoplegia (External Ophthalmoplegia) 06/2007 - 03/2003
2	Myotonia 09/2006 - 11/2004
1	Progressive Multifocal Leukoencephalopathy 07/2021

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2005
9	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 08/2007
9	AutoantibodiesIBA 01/2018 - 10/2003
8	Cholinergic ReceptorsIBA 01/2020 - 01/2004
7	AntibodiesIBA 01/2020 - 08/2007
5	ConnectinIBA 12/2018 - 12/2008
4	CollagenIBA 01/2021 - 10/2004
4	DystrophinIBA 08/2019 - 11/2004
4	Sodium Channels (Sodium Channel)IBA 04/2015 - 10/2004
4	DysferlinIBA 02/2009 - 08/2005
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 10/2003
3	CalciumIBA 01/2020 - 02/2013
3	Biomarkers (Surrogate Marker)IBA 08/2019 - 02/2014
3	DesminIBA 06/2018 - 07/2005
3	Signal Recognition ParticleIBA 01/2018 - 07/2011
3	GlycogenIBA 12/2017 - 09/2003
3	AgrinIBA 09/2014 - 08/2009
3	Protein Isoforms (Isoforms)IBA 07/2014 - 09/2004
3	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 11/2004
3	muskIBA 01/2013 - 12/2004
2	Extracellular Matrix ProteinsIBA 01/2021 - 10/2010
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2021 - 11/2017
2	Protein AggregatesIBA 06/2018 - 06/2010
2	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 02/2014
2	Complement System Proteins (Complement)IBA 01/2018 - 10/2003
2	Rituximab (Mabthera)FDA Link 01/2018 - 03/2017
2	Glycogen Debranching Enzyme System (Glycogen Debranching Enzyme)IBA 11/2017 - 05/2015
2	Calcium Channels (Calcium Channel)IBA 09/2017 - 11/2004
2	EnzymesIBA 08/2017 - 08/2010
2	AntigensIBA 02/2017 - 08/2007
2	human GAA protein (Myozyme)FDA Link 01/2017 - 07/2011
2	CalpainIBA 01/2016 - 12/2015
2	Mitochondrial DNA (mtDNA)IBA 11/2015 - 06/2007
2	Sarcoglycans (beta Sarcoglycan)IBA 04/2015 - 02/2012
2	SodiumIBA 04/2015 - 11/2004
2	Dynamin IIIBA 12/2014 - 11/2005
2	Proteoglycans (Proteoglycan)IBA 09/2014 - 12/2013
2	TropomyosinIBA 07/2014 - 12/2013
2	Messenger RNA (mRNA)IBA 03/2014 - 02/2014
2	SteroidsIBA 06/2011 - 06/2008
2	ChloridesIBA 09/2006 - 11/2004
2	peripheral membrane protein 43KIBA 10/2004 - 01/2004
1	Immune Checkpoint InhibitorsIBA 07/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021

Therapy/Procedure

6	Therapeutics 01/2021 - 05/2005
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2019 - 01/2017
2	Activities of Daily Living (ADL) 01/2018 - 01/2017
2	Enzyme Replacement Therapy 01/2017 - 07/2011
2	Heart Transplantation (Grafting, Heart) 11/2015 - 12/2013